{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:14:45Z","timestamp":1771467285366,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundaci\u00f3n Bancaria Caixa d'Estalvis i Pensions de Barcelona","doi-asserted-by":"publisher","award":["100010434"],"award-info":[{"award-number":["100010434"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundaci\u00f3n Bancaria Caixa d'Estalvis i Pensions de Barcelona","doi-asserted-by":"publisher","award":["LCF\/BQ\/DI20\/11780008"],"award-info":[{"award-number":["LCF\/BQ\/DI20\/11780008"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["2020_FI_B_00276"],"award-info":[{"award-number":["2020_FI_B_00276"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clinre.2020.11.001","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:14:47Z","timestamp":1616087687000},"page":"101564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-2299","authenticated-orcid":false,"given":"Jeffrey V","family":"Lazarus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila A","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cary","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice A.","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"\u00d8vrehus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Turnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Ustianowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2020.11.001_bib0005","series-title":"WHO | global hepatitis report, 2017","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.clinre.2020.11.001_bib0010","series-title":"Global health sector strategy (GHSS) on viral hepatitis 2016-2021; Geneva","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.clinre.2020.11.001_bib0015","series-title":"Global timing of hepatitis C virus elimination in high-income countries: an updated analysis. In international liver congress 2020; London","author":"Razavi","year":"2020"},{"issue":"0","key":"10.1016\/j.clinre.2020.11.001_bib0020","article-title":"Global hepatitis C elimination: an investment framework","volume":"0","author":"Pedrana","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2020.11.001_bib0025","series-title":"The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations. Seminars in liver disease. Thieme medical publishers, Inc. August 1","first-page":"181","author":"Lazarus","year":"2018"},{"key":"10.1016\/j.clinre.2020.11.001_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bmjgast-2020-000396","article-title":"Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C","volume":"7","author":"Isfordink","year":"2020","journal-title":"BMJ Open Gastro"},{"key":"10.1016\/j.clinre.2020.11.001_bib0035","unstructured":"NHS Tayside claims it has \u201ceffectively eliminated\u201d hepatitis C - BBC News https:\/\/www.bbc.com\/news\/uk-scotland-tayside-central-53558315 (accessed Aug 3, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0040","unstructured":"NHS Tayside first region in the world to eliminate hepatitis C | University of Dundee https:\/\/www.dundee.ac.uk\/stories\/nhs-tayside-first-region-world-eliminate-hepatitis-c (accessed Aug 3, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination - a path to global elimination of hepatitis C","volume":"67","author":"Lazarus","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2020.11.001_bib0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/joim.12972","article-title":"We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade","volume":"286","author":"Lazarus","year":"2019","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.clinre.2020.11.001_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-8510(00)00138-X","article-title":"What Is \u201cbest Practice\u201d in Health Care? State of the Art and Perspectives in Improving the Effectiveness and Efficiency of the European Health Care Systems","volume":"56","author":"Perleth","year":"2001","journal-title":"Health Policy (New. York)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0060","series-title":"WHO | a guide to identifying and documenting best practices in family planning programmes","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.clinre.2020.11.001_bib0065","series-title":"Winning the race to eliminate hepatitis C: accelerating efforts together to reach the world health organization\u2019s 2030 elimination targets","author":"Boston Consulting Group","year":"2020"},{"key":"10.1016\/j.clinre.2020.11.001_bib0070","series-title":"Compendium of good practices in the health sector response to viral hepatitis in the WHO european region","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.clinre.2020.11.001_bib0075","series-title":"Stories to inspire:how national, regional, and local initiatives are helping to achieve viral hepatitis elimination","author":"Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe (ACHIEVE)","year":"2017"},{"key":"10.1016\/j.clinre.2020.11.001_bib0080","series-title":"Too many people with viral hepatitis are diagnosed late \u2014 with dire consequences. Nature reviews gastroenterology and hepatology. Nature publishing group August 1","first-page":"451","author":"Lazarus","year":"2019"},{"issue":"2","key":"10.1016\/j.clinre.2020.11.001_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults-united states, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"10.1016\/j.clinre.2020.11.001_bib0090","first-page":"351","article-title":"Implementation and evaluation of a multicomponent quality improvement intervention to improve efficiency of hepatitis C screening and diagnosis","volume":"40","author":"Hirsch","year":"2014","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.clinre.2020.11.001_bib0095","article-title":"Hepatitis C reflex testing in Spain in 2019: a story of success","author":"Crespo","year":"2020","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.clinre.2020.11.001_bib0100","unstructured":"Cepheid. Xpert\u00ae Xpress SARS-CoV-2 has received FDA Emergency Use Authorization https:\/\/www.cepheid.com\/coronavirus (accessed Jul 29, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0105","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2018.05.017","article-title":"New Virological Tools for Screening, Diagnosis and Monitoring of Hepatitis B and C in Resource-Limited Settings","author":"Chevaliez","year":"2018","journal-title":"Journal of Hepatology. Elsevier B.V."},{"key":"10.1016\/j.clinre.2020.11.001_bib0110","unstructured":"National Institute for Health and Care Excellence. FibroScan for assessing liver fibrosis and cirrhosis in primary care | Advice | NICE https:\/\/www.nice.org.uk\/advice\/mib216\/chapter\/summary (accessed Jul 29, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0115","series-title":"Redundancy of elastography in mono-infected HCV individuals less than 30 years old-development of Dillon\u2019s rule. In international liver conference; Vienna","author":"Brennan","year":"2019"},{"key":"10.1016\/j.clinre.2020.11.001_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijid.2019.09.022","article-title":"Hepatitis C core antigen: diagnosis and monitoring of patients infected with hepatitis C virus","volume":"89","author":"P\u00e9rez-Garc\u00eda","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.clinre.2020.11.001_bib0125","series-title":"Guidelines on hepatitis B and C testing; Geneva","author":"World Health Organization","year":"2017"},{"issue":"12","key":"10.1016\/j.clinre.2020.11.001_bib0130","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/infdis\/jiaa037","article-title":"Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis","volume":"221","author":"Grebely","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinre.2020.11.001_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102755","article-title":"Peer outreach point-of-Care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada","volume":"80","author":"Broad","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.clinre.2020.11.001_bib0140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/liv.14315","article-title":"In\u2010field Evaluation of Xpert\u00ae HCV Viral Load Fingerstick Assay in People Who Inject Drugs in Tanzania","volume":"40","author":"Mohamed","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2020.11.001_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102734","article-title":"Evaluation of the Xpert HCV VL Fingerstick Point-of-Care Assay and Dried Blood Spot HCV-RNA Testing as Simplified Diagnostic Strategies among People Who Inject Drugs in Catalonia, Spain","volume":"80","author":"Saludes","year":"2020","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinre.2020.11.001_bib0150","series-title":"Protocol de diagn\u00f2stic i tractament del virus de l\u2019hepatitis C per persones drogodependents","author":"Generalitat de Catalunya","year":"2020"},{"key":"10.1016\/j.clinre.2020.11.001_bib0155","unstructured":"National Institute for Health and Clinical Excellence (NICE). Hepatitis B and C: Ways to Promote and Offer Testing to People at Increased Risk of Infection."},{"issue":"12","key":"10.1016\/j.clinre.2020.11.001_bib0160","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jech-2014-204451","article-title":"Rise in testing and diagnosis associated with Scotland\u2019s action plan on hepatitis C and introduction of dried blood spot testing","volume":"68","author":"McLeod","year":"2014","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.clinre.2020.11.001_bib0165","series-title":"Place des tests rapides d\u2019orientation diagnostique (TROD) dans La strat\u00e9gie de d\u00e9pistage de l\u2019h\u00e9patites","author":"Haute Autorit\u00e9 Sant\u00e9","year":"2014"},{"issue":"4","key":"10.1016\/j.clinre.2020.11.001_bib0170","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2020.11.001_bib0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2019.01.012","article-title":"Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care","volume":"70","author":"Papaluca","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinre.2020.11.001_bib0180","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment eradication of hepatitis C: a novel treatment paradigm","volume":"113","author":"Cuadrado","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2020.11.001_bib0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4321\/S1575-06202019000100006","article-title":"Is it possible to eliminate hepatitis C from the prisons of Catalonia, Spain, in 2021?","volume":"21","author":"Marco","year":"2019","journal-title":"Rev. Espa\u00f1ola Sanid. Penit."},{"issue":"3","key":"10.1016\/j.clinre.2020.11.001_bib0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcv.2014.09.004","article-title":"Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland","volume":"61","author":"McAllister","year":"2014","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.clinre.2020.11.001_bib0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/flgastro-2016-100776","article-title":"A Quasi-Experimental Evaluation of Dried Blood Spot Testing through Community Pharmacies in the Tayside Region of Scotland","volume":"8","author":"Radley","year":"2017","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2020.11.001_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231385","article-title":"Dried blood spot self-sampling at home is a feasible technique for hepatitis C RNA detection","volume":"15","author":"Prinsenberg","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2020.11.001_bib0205","series-title":"Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission. The lancet gastroenterology and hepatology. Elsevier ltd February 1","first-page":"135","author":"Cooke","year":"2019"},{"key":"10.1016\/j.clinre.2020.11.001_bib0210","series-title":"The future of viral hepatitis testing: innovations in testing technologies and approaches. BMC infectious diseases. BioMed central Ltd. November 1","first-page":"699","author":"Peeling","year":"2017"},{"key":"10.1016\/j.clinre.2020.11.001_bib0215","series-title":"WHO | guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. WHO","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.clinre.2020.11.001_bib0220","unstructured":"EASL. Global hepatology societies call for better HCV testing and access to treatment - EASL-The Home of Hepatology. https:\/\/easl.eu\/press-release\/global-hepatology-societies-call-for-better-hcv-testing-and-access-to-treatment\/ (accessed Jul 29, 2020)."},{"issue":"1","key":"10.1016\/j.clinre.2020.11.001_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41124-018-0035-6","article-title":"Drug consumption rooms (DCRs) as a setting to address hepatitis C \u2013 findings from an international online survey","volume":"3","author":"Belackova","year":"2018","journal-title":"Hepatol Med Policy"},{"key":"10.1016\/j.clinre.2020.11.001_bib0230","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.dld.2019.12.111","article-title":"\u201cThe \u2018Caserta model\u2019. An HCV way out in persons who use drugs (PWUD) in Italy","volume":"52","author":"Messina","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2020.11.001_bib0235","series-title":"The cost benefits for health system in treating PWIDs with chronic hepatitis C: evidence form real practice | lisbon addictions 2019. In european conference on addictive behaviours and dependencies; Lisbon","author":"Nava","year":"2019"},{"key":"10.1016\/j.clinre.2020.11.001_bib0240","series-title":"A model of care for people attending drug treatment centers aiming at hepatitis c elimination by 2022. A part of the c- free south strategy. In INSHU; montr\u00e9al","author":"Dr\u00f6se","year":"2019"},{"issue":"3","key":"10.1016\/j.clinre.2020.11.001_bib0245","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/add.14479","article-title":"Test uptake and hepatitis C prevalence in 5483 danish people in drug use treatment from 1996 to 2015: a registry-based cohort study","volume":"114","author":"\u00d8vrehus","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.clinre.2020.11.001_bib0250","series-title":"EASL position statement on liver disease and migrant health","author":"EASL","year":"2018"},{"key":"10.1016\/j.clinre.2020.11.001_bib0255","series-title":"Is it possible to successfully link migrants to HBV, HCV and HIV services upon arrival in the european union?","author":"Prestileo","year":"2019"},{"key":"10.1016\/j.clinre.2020.11.001_bib0260","series-title":"Integrated approach to hepatitis C services for refugees in rural and Outer Urban Victoria. What parallels apply when developing services for indigenous communities. In world indigenous peoples\u2019 conference on viral hepatitis; Alice Springs","author":"Watkinson","year":"2014"},{"issue":"12","key":"10.1016\/j.clinre.2020.11.001_bib0265","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and treatment program to eliminate hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2020.11.001_bib0270","unstructured":"KOMBI CLINIC CASE STUDY | Hepatic Health https:\/\/www.hepatichealth.com\/kombi-clinic-case-study\/ (accessed Jul 29, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0275","unstructured":"Resultados \u2013 Unidad M\u00f3vil de Cribado https:\/\/unidadmovil.es\/consultar-resultado\/ (accessed Jul 29, 2020)."},{"issue":"10","key":"10.1016\/j.clinre.2020.11.001_bib0280","article-title":"HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: breaking barriers for HCV elimination","volume":"13","author":"La Rosa","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clinre.2020.11.001_bib0285","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s10900-014-9932-9","article-title":"Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-Care and standard HCV testing in a mobile medical clinic","volume":"39","author":"Morano","year":"2014","journal-title":"J Community Health"},{"key":"10.1016\/j.clinre.2020.11.001_bib0290","series-title":"A novel hepatitis C intervention in Denmark to test and treat people who inject drugs. In digital international liver conference","author":"Lazarus","year":"2020"},{"issue":"4","key":"10.1016\/j.clinre.2020.11.001_bib0295","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.japh.2017.04.463","article-title":"Pharmacists performing hepatitis C antibody point-of-Care screening in a community pharmacy: a pilot project","volume":"57","author":"Dong","year":"2017","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.clinre.2020.11.001_bib0300","first-page":"98","article-title":"Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States","volume":"13","author":"Kugelmas","year":"2017","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.clinre.2020.11.001_bib0305","series-title":"HCV testing in NSP (Needle and syringe provision) community pharmacies pilot (Phase 1) report and findings","author":"Suman Verma","year":"2018"},{"key":"10.1016\/j.clinre.2020.11.001_bib0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugpo.2017.05.042","article-title":"DOT-C: A Cluster Randomised Feasibility Trial Evaluating Directly Observed Anti-HCV Therapy in a Population Receiving Opioid Substitute Therapy from Community Pharmacy","volume":"47","author":"Radley","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.clinre.2020.11.001_bib0315","series-title":"Integrated care of severe infectious diseases to people with substance use disorders; a systematic review. BMC infectious diseases. BioMed central Ltd. April 4","first-page":"306","author":"Vold","year":"2019"},{"issue":"6","key":"10.1016\/j.clinre.2020.11.001_bib0320","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/dar.12978","article-title":"Barriers to effective management of hepatitis C virus in people who inject drugs: evidence from outpatient clinics","volume":"38","author":"Molinaro","year":"2019","journal-title":"Drug Alcohol Rev"},{"issue":"11","key":"10.1016\/j.clinre.2020.11.001_bib0325","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/jvh.13175","article-title":"Treatment adherence and support for people who inject drugs taking direct-acting antiviral therapy for hepatitis C infection","volume":"26","author":"Read","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2020.11.001_bib0330","series-title":"Organizational barries as an explanation for differences in offer and uptake rates for hepatitis A\/B\/C and HIV testing in three drug treatment centres in Copenhagen. In HepHIV 2017; Malta","author":"Linnet","year":"2017"},{"issue":"1","key":"10.1016\/j.clinre.2020.11.001_bib0335","first-page":"1","article-title":"Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017","volume":"15","author":"Aas","year":"2020","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"issue":"6","key":"10.1016\/j.clinre.2020.11.001_bib0340","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/jvh.13268","article-title":"A same day \u2018Test and treat\u2019 model for chronic HCV and HBV infection: results from two community\u2010based pilot studies in Egypt","volume":"27","author":"Shiha","year":"2020","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.clinre.2020.11.001_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12916-019-1300-2","article-title":"Improving Engagement with Healthcare in Hepatitis C: A Randomised Controlled Trial of a Peer Support Intervention","volume":"17","author":"Stagg","year":"2019","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.clinre.2020.11.001_bib0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12954-017-0192-8","article-title":"Perceived benefits of the hepatitis C peer educators: a qualitative investigation","volume":"14","author":"Batchelder","year":"2017","journal-title":"Harm Reduct J"},{"issue":"8","key":"10.1016\/j.clinre.2020.11.001_bib0355","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/liv.14469","article-title":"Frequent Loss to Follow\u2010up after Diagnosis of Hepatitis C Virus Infection: A Barrier towards the Elimination of Hepatitis C Virus","volume":"40","author":"Aleman","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2020.11.001_bib0360","unstructured":"Van Dijk, M.; Kracht, P. A. M.; Arends, J. E.; Blokzijl, H.; Burger, D. M.; Van Erpecum, K. J.; Van Hoek, B.; De Knegt, R. J.; Posthouwer, D.; Ramsoekh, D.; et al. Retrieval of Chronic Hepatitis C Patients. A Manifesto for Action to Eliminate Hepatitis C in the Netherlands: The CELINE Project."},{"issue":"1","key":"10.1016\/j.clinre.2020.11.001_bib0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41124-018-0032-9","article-title":"Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the northern holland hepatitis retrieval project","volume":"3","author":"Beekmans","year":"2018","journal-title":"Hepatol Med Policy"},{"issue":"8","key":"10.1016\/j.clinre.2020.11.001_bib0370","first-page":"737","article-title":"Improving outcome in hepatitis C management: a need for dedicated multi-disciplinary service to improve compliance with treatment","volume":"2","author":"Ahmed","year":"2013","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"11","key":"10.1016\/j.clinre.2020.11.001_bib0375","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.cgh.2015.02.022","article-title":"Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse","volume":"13","author":"Ho","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2020.11.001_bib0380","unstructured":"European Centre for Disease Prevention and Control (ECDC). Public Health Guidance on HIV, Hepatitis B and C Testing in the EU\/EEA."},{"key":"10.1016\/j.clinre.2020.11.001_bib0385","unstructured":"Simoes D., F. R. R. M. et al. Scaling up Standards, Testing and Linkage to Care: Implementation of a Portuguese Community-Based Screening Network."},{"key":"10.1016\/j.clinre.2020.11.001_bib0390","first-page":"e42","article-title":"PS-071-piloting of integrated HCV, TB and HIV screening model at primary care level in Georgia","volume":"70","author":"Khonelidze","year":"2019"},{"issue":"6","key":"10.1016\/j.clinre.2020.11.001_bib0395","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MLR.0000000000000715","article-title":"An electronic health record-based intervention to promote hepatitis C virus testing among adults born between 1945 and 1965: a cluster-randomized trial","volume":"55","author":"Federman","year":"2017","journal-title":"Med Care"},{"issue":"11","key":"10.1016\/j.clinre.2020.11.001_bib0400","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.2105\/AJPH.2012.300659","article-title":"Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting","volume":"102","author":"Drainoni","year":"2012","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.clinre.2020.11.001_bib0405","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.dld.2011.12.014","article-title":"Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk","volume":"44","author":"Litwin","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2020.11.001_bib0410","series-title":"Action plan for the prevention, care, & treatment of viral hepatitis","author":"Koh","year":"2014"},{"key":"10.1016\/j.clinre.2020.11.001_bib0415","series-title":"Expanding access to hepatitis C virus treatment - extension for community healthcare outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology. NIH public access September","first-page":"1124","author":"Arora","year":"2010"},{"key":"10.1016\/j.clinre.2020.11.001_bib0420","series-title":"Community hep program Jennifer Broad, T. C.; community hep program jac atkinson, T. C.; Halifax, M. Expanding hepatitis C testing and treatment through task shifting PRESENTED BY","author":"Kushner","year":"2019"},{"issue":"5","key":"10.1016\/j.clinre.2020.11.001_bib0425","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M17-0118","article-title":"Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers a Nonrandomized Clinical Trial","volume":"167","author":"Kattakuzhy","year":"2017","journal-title":"Ann Intern Med"},{"issue":"7\/8","key":"10.1016\/j.clinre.2020.11.001_bib0430","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14745\/ccdr.v44i78a02","article-title":"Awareness and knowledge of hepatitis C among health care providers and the public: a scoping review","volume":"44","author":"Ha","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.clinre.2020.11.001_bib0435","series-title":"Hepatitis and liver Cancer: a national strategy for prevention and control of hepatitis B and C","author":"Colvin","year":"2010"},{"key":"10.1016\/j.clinre.2020.11.001_bib0440","unstructured":"World Hepatitis Alliance. World Hepatitis Day 2019 Global Summary Report."},{"key":"10.1016\/j.clinre.2020.11.001_bib0445","unstructured":"DU BRUIT CONTRE L\u2019H\u00c9PATITE C - Addiction Agency. https:\/\/www.addiction-agency.com\/fr\/projets\/dubruitcontrelhepatitec\/ (accessed Jul 29, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0450","series-title":"Screening for chronic viral hepatitis in migrant populations report on four HEPscreen pilot studies screening for chronic viral hepatitis in migrant populations report on four HEPscreen pilot studies work package 6 report","author":"Fernandez","year":"2014"},{"issue":"4","key":"10.1016\/j.clinre.2020.11.001_bib0455","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eimc.2018.05.016","article-title":"Luis Calleja Panero, J.; Garc\u00eda, F. Diagnosis of Hepatitis C Virus Infection in Spain: An Opportunity to Improve","volume":"37","author":"Crespo","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.clinre.2020.11.001_bib0460","series-title":"Optimising treatment in the test-and-Treat strategy: what are we waiting for? The lancet HIV","first-page":"e715","author":"Phanuphak","year":"2019"},{"key":"10.1016\/j.clinre.2020.11.001_bib0465","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugpo.2019.02.013","article-title":"Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting","volume":"72","author":"Overton","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"12","key":"10.1016\/j.clinre.2020.11.001_bib0470","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz714","article-title":"The consensus hepatitis C cascade of care: standardized reporting to monitor progress toward elimination | request PDF","volume":"69","author":"Safreed Harmon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2020.11.001_bib0475","unstructured":"World Health Organization. WHO urges countries to invest in eliminating hepatitis https:\/\/www.who.int\/news-room\/detail\/26-07-2019-who-urges-countries-to-invest-in-eliminating-hepatitis (accessed Jul 30, 2020)."},{"key":"10.1016\/j.clinre.2020.11.001_bib0480","unstructured":"Kirby Institute. Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs: TEMPO - ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04014179 (accessed Aug 4, 2020)."},{"issue":"12","key":"10.1016\/j.clinre.2020.11.001_bib0485","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/jvh.12966","article-title":"The Hepatitis C Cascade of Care in People Who Inject Drugs in Dar Es Salaam, Tanzania","volume":"25","author":"Mohamed","year":"2018","journal-title":"J Viral Hepat"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120303053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740120303053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:31:21Z","timestamp":1761895881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740120303053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2210740120303053"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2020.11.001","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101564"}}